PURR Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$13.05median target· current $6.21 (+110.1%)3 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
48 articles · sorted by datePage 1 of 3 · 48 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)—0.0% YoY
Profit margin0.0%FINANCIAL SERVICES
Market cap$1.25BSmall cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 0.0%
- Operating margin
- 7381.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- —
Last earnings
May 7, 2026 · Estimate $0.21 · Reported $1.01
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Hyperliquid Strategies Inc Common Stock
Company profileHyperliquid Strategies Inc., through its subsidiary, is a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company is headquartered in New York, New York.
Classification
- Sector
- Financial Services
- Industry
- Capital Markets
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 477 MADISON AVENUE, NEW YORK, NY
- Latest quarter
- Mar 31, 2026
Market cap$1.25B
Shares outstanding$200.6M
52W high$11.62
52W low$3.01
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent